MedReleaf Launches AltaVie, a Premium Cannabis Brand Designed with the Higher-End, Wellness-Focused Consumer in Mind
AltaVie by MedReleaf aims to help make mindfulness more attainable
MARKHAM, ON, April 3, 2018 /CNW/ - MedReleaf Corp. (TSX:LEAF) Canada's first and only ISO 9001 and ICH-GMP certified cannabis producer, today announced the introduction of AltaVie by MedReleaf, the Company's premium recreational cannabis brand designed for a premium consumer who is curious, discerning about life in general and searching for physical, mental and emotional enrichment.
The AltaVie product line up will contain a robust assortment of premium offerings, putting an emphasis on strains and forms that will be equally popular with the premium consumer, those new to cannabis and those interested in the wellness category, helping each segment get more out of life.
To officially launch the brand, AltaVie will host an immersive evening of mindfulness, art and living in the moment, in Toronto on April 5, 2018. Visionary poet Cleo Wade will be in attendance, and Toronto artists including Briony Douglas, Alpo Snow, Tahsin- The Good and Enzee Creative (Natasha Wiseman and Zac Booth) will have new works on display, inspired by the concept of what living in the now means to them.
"We are living in a fast-paced world that has us all constantly looking to the future and focused on getting somewhere or the next thing" noted Darren Karasiuk, VP Strategy at MedReleaf. "While the benefits of cannabis are far-reaching, for the launch of AltaVie we want to focus on the power of being in the present, allowing our consumer to appreciate life's moments more fully – in the here and now, big or small."
While a full suite of cannabis-based AltaVie products and experiences will be introduced to the marketplace as regulations allow, MedReleaf has already launched a cannabis-free product into the Canadian marketplace in the form of AltaVie Cannabis Crunch. Infused with cannabis-inspired flavours, Cannabis Crunch is our way of introducing new or lapsed consumers to the complexity and depth of cannabis flavours and to build brand awareness. The product is available in over 200, health food, drug and grocery stores across Canada.
"With the launch of AltaVie, MedReleaf reinforces its position as a leader in the industry, adding to a portfolio of brands to meet the diverse needs of Canadians," noted Neil Closner, CEO of MedReleaf. "With AltaVie, we now have a premium wellness line that complements our recreational and medical brands, all of which lever the company's award-winning products, leading quality and production standards."
About MedReleaf Corp.
Voted Top Licensed Producer at the 2017 Lift Canadian Cannabis Awards, MedReleaf is an R&D- driven company dedicated to innovation, operational excellence and the production of top- quality cannabis. Sourced from around the world and carefully cultivated in one of two state-of-the-art ICH-GMP and ISO 90001 certified facilities in Ontario, the Company delivers a variety of premium products for the global medical market and is committed to serving the therapeutic needs of its medical patients and providing a compelling product assortment for the adult-use recreational consumer.
For more information on AltaVie please visit altavie.ca and follow our journey here: @altavieoffical
SOURCE MedReleaf Corp.
Media Contact: Katie Mills, Narrative, Phone: 416.625.6267, [email protected]
Share this article